Evidence map›Paper›PMID 24172014›Full record

ReviewHuman genomics2013

Update of the human and mouse SERPIN gene superfamily.

Claire Heit, Brian C Jackson, Monica McAndrews, Mathew W Wright, David C Thompson, Gary A Silverman, Daniel W Nebert, Vasilis Vasiliou

Open access · goldAbstract readReview
In one paragraph

Review in Human genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 3 syntheses or guidelines pooled it, 263 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Effect ofBiomedicines · 2026
    Article
  14. Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  15. mSphere · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes.Cellular and molecular life sciences : CMLS · 2025
    Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Claire Heit
Brian C Jackson
Monica McAndrews
Mathew W Wright
David C Thompson
Gary A Silverman
Daniel W NebertDepartment of Pharmaceutical Sciences, Molecular Toxicology and Environmental Health Sciences Program, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA. dan.nebert@uc.edu.
Vasilis Vasiliou
University of Colorado Anschutz Medical Campus · USEuropean Bioinformatics Institute · GBJackson Laboratory · USUniversity of Cincinnati Medical Center · USUniversity of Colorado Boulder · USUniversity of Pittsburgh · US

Funding

SOFTWARE AND DATABASE SYSTEM DEVELOPMENTP41HG000330 · NHGRI · JACKSON LABORATORY · PI EPPIG, JANAN T. · 1995 to 2010
$72.1M
REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI MEDVEDOVIC, MARIO · 1992 to 2022
$35.4M
Mouse Models for Alcohol Metabolism and Tissue InjuryR24AA022057 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2013 to 2022
$4.5M
Nomenclature of Human and Vertebrate GenesU41HG003345 · NHGRI · EUROPEAN MOLECULAR BIOLOGY LABORATORY · PI BIRNEY, EWAN, BRUFORD, ELSPETH · 2013 to 2017
$2.4M
Biochemical, Structural and Polymorphic Characterization of Human ALDH1B1F31AA020728 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI JACKSON, BRIAN CHRISTOPHER · 2011 to 2014
$104k
MULTI-LEVEL ANALYSIS AND DISPLAY OF MOUSE GENOME DATAP01HG000330 · NHGRI · JACKSON LABORATORY · PI EPPIG, JANAN T. · 1990 to 1994
–
NHGRI NIH HHS HG000330NHGRI NIH HHS U41HG003345NIAAA NIH HHS F31 AA020728NIAAA NIH HHS R24 AA022057NIEHS NIH HHS P30 ES006096NIEHS NIH HHS P30 ES06096Wellcome Trust 099129/Z/12/Z
6 · The paper itself

Abstract

The serpin family comprises a structurally similar, yet functionally diverse, set of proteins. Named originally for their function as serine proteinase inhibitors, many of its members are not inhibitors but rather chaperones, involved in storage, transport, and other roles. Serpins are found in genomes of all kingdoms, with 36 human protein-coding genes and five pseudogenes. The mouse has 60 Serpin functional genes, many of which are orthologous to human SERPIN genes and some of which have expanded into multiple paralogous genes. Serpins are found in tissues throughout the body; whereas most are extracellular, there is a class of intracellular serpins. Serpins appear to have roles in inflammation, immune function, tumorigenesis, blood clotting, dementia, and cancer metastasis. Further characterization of these proteins will likely reveal potential biomarkers and therapeutic targets for disease.

Indexed as

AnimalsDisease Models, AnimalEvolution, MolecularGenetic VariationHumansMiceMultigene FamilyPhylogenyProtein ConformationSerpinsSerpins

Identifiers

PMID24172014
PMCPMC3880077
OpenAlexW2112289496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.